Richard Harris
Stories
-
3 Questions And The Emerging Answers About COVID-19 Vaccine Protection
First, can someone who has been vaccinated still spread the disease? Second, will the vaccine remain effective as the virus itself evolves? And third, how long will the vaccine's protection last?
-
Doctors Encouraged By Antibody Treatments For COVID-19
While logistical challenges have hampered use of antibody drugs to treat people with mild-to-moderate COVID-19, recent results show the medicines can be worthwhile.
-
All Things Considered
Doses Of Antibody Drugs Remain Unused As They Present Various Challenges
Monoclonal antibody drugs for COVID-19 with mild to moderate symptoms are not widely used, in part because doctors aren't sure they work. New data could provide more confidence in these drugs.
-
Morning Edition
Low Demand For Antibody Drugs Against COVID-19
Monoclonal antibodies to prevent severe COVID-19 aren't being used as widely as expected. Medical staff shortages and patient transportation problems are two of the reasons.
-
All Things Considered
Latest On FDA Authorization For Moderna's COVID-19 Vaccine
The Food and Drug Administration says it will soon grant emergency authorization to Moderna's COVID-19 vaccine. NPR shares the latest news.
-
All Things Considered
Oxygen-Detecting Devices Give Misleading Readings In People With Dark Skin
Common devices to measure oxygen in the blood don't work as well in people with darker skin, according to a new study. They are useful, but experts warn readings should be interpreted more carefully.
-
Devices Used In COVID-19 Treatment Can Give Errors For Patients With Dark Skin
Fingertip devices that measure oxygen in the blood can sometimes give erroneous readings in people with dark skin, doctors report. The devices can say oxygen levels are normal when they're not.
-
All Things Considered
FDA Approves Pfizer's COVID-19 Vaccine For Distribution
Pfizer may now start shipping the inoculation to hospitals across the country. Health care workers and people in nursing homes and assisted living centers will be given priority for the vaccine.
-
All Things Considered
What To Expect From FDA Advisory Committee's COVID-19 Vaccine Meeting?
A Food and Drug Administration advisory committee is preparing to vote on whether to recommend Pfizer's COVID-19 vaccine for emergency use in the United States.
-
Morning Edition
FDA Panel Will Weigh Benefits, Risks Of Pfizer's COVID-19 Vaccine
A federal advisory committee is evaluating Pfizer's COVID-19 vaccine. The Food and Drug Administration will weigh that input as it decides whether to grant emergency use for the vaccine.